Insider Monkey
enGene Holdings Inc (ENGN) Surging After Positive Phase 2 LEGEND Trial
📈
AI Sentiment
Highly Positive
8/10
- Home
- ENGN
ENGN
enGene Holdings Inc.
as of 12-05-2025 4:00pm EST
$8.07
$0.15
-1.82%
Stocks Nasdaq
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Chart Type:
Time Range:
| Founded: | 1999 | Country: | Canada |
| Employees: | N/A | City: | SAINT-LAURENT |
| Market Cap: | 379.3M | IPO Year: | N/A |
| Target Price: | $22.71 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.65 - $11.14 | Next Earning Date: | 12-19-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered ENGN Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 79.01%
79.01%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest enGene Holdings Inc. News
ENGN Breaking Stock News: Dive into ENGN Ticker-Specific Updates for Smart Investing
MT Newswires
EnGene Says US FDA Selects Detalimogene for Manufacturing Pilot Program
📊
AI Sentiment
Positive
6/10
Business Wire
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
📈
AI Sentiment
Highly Positive
8/10
Compare ENGN vs Leading Stocks
See how ENGN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ENGN enGene Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.